Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank50
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-3.69M
↓ 40% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-2.64M
Historical baseline
PeriodValueYoY Change
2025$-3.69M+27.3%
2024$-5.07M-31.4%
2023$-3.86M-723.6%
2022$-468661.00-292.5%
2021$-119396.00-